N-Power Medicine and AdventHealth Collaborate to Expand Access to Cancer Care and Research

New collaboration integrates prospective, trial-grade clinical research into routine oncology care, giving patients more options for cancer care closer to home

REDWOOD CITY, Calif.--(BUSINESS WIRE)--N-Power Medicine, a company revolutionizing oncology drug development, and AdventHealth, a faith-based health system focused on whole-person care, today announced a strategic collaboration to make clinical research more accessible for people receiving cancer care in their communities.

Through this collaboration, AdventHealth will integrate N-Power’s Kaleido™ Registry and Prospective External Control Arm (ProECA) platform into routine oncology care at select locations across its cancer care network in Colorado, Kansas, Georgia, and Florida, beginning this month.

AdventHealth’s research infrastructure spans multiple states and specialties, supporting more than 800 active clinical studies and hundreds of investigators working together to advance whole-person care. That foundation enables collaborations like this one, where research can be thoughtfully integrated into routine clinical care while maintaining rigorous oversight and patient safety.

“Access to high-quality clinical care is an important part of helping people feel whole during some of the most difficult moments of their lives,” said Michael Cacciatore, MD, Chief Clinical Officer of AdventHealth. “This collaboration allows us to expand access to research opportunities, especially in community and rural settings, so patients can benefit from the latest advances in cancer care close to home.”

At the core of N-Power’s platform is the Kaleido Registry infrastructure, which seamlessly incorporates trial-grade data collection and workflows into routine clinical care delivery. This platform enables the generation of high-quality external control data and supports the efficient conduct of clinical trials. Through this model, N-Power broadens access to clinical trials for patients where they receive care, including novel trials utilizing ProECA, with reduced reliance on traditional randomized control groups.

“Our goal is to minimize the operational divide that has traditionally separated clinical care from clinical research,” said Michael Seiden, Chief Medical Officer of N-Power Medicine. “By providing both cutting-edge technology and a team of dedicated research professionals to AdventHealth, we enable community oncologists to actively participate in research and bring more therapies to patients faster.”

Together, AdventHealth and N-Power are advancing a more connected, patient-centered approach to oncology research, one that brings clinical trials closer to home and supports better outcomes for patients, families, and communities.

About N-Power Medicine

N-Power Medicine is leading a revolution in how oncology trials are designed and conducted. Through a next-generation network of community oncologists and proprietary infrastructure, N-Power delivers faster, smarter clinical trials powered by a first-of-its-kind always-on external control arm embedded in routine care. By enabling drug developers to move beyond traditional randomized clinical trials, N-Power dramatically accelerates drug development timelines, broadens access to clinical trials in the community, and brings transformative therapies to patients faster.

For more information about N-Power Medicine, visit npowermedicine.com.

About AdventHealth

AdventHealth is a connected network of care that helps people feel whole – body, mind and spirit. More than 100,000 team members across a national footprint provide whole-person care for millions of people annually through more than 2,000 care sites that include hospitals, physician practices, ambulatory surgery centers, outpatient clinics, home health agencies, hospice centers, the AdventHealth app and more. Our wholistic approach to improving the health and prosperity of our communities is inspired by our mission to extend the healing ministry of Christ. ​For the latest news about AdventHealth, visit www.AdventHealth.com/news.